They may offer other health benefits as well, such as support for heart health, PCOS symptom management, and help with addiction treatment
(This is associative evidence and may reflect confounding by indication, surveillance patterns, and glycaemic differences.) For post-marketing pharmacovigilance, FAERS-based analyses of semaglutide identify multiple safety signals (e.g., gastrointestinal obstruction-related terms, dehydration/volume depletion in some GLP-1RA analyses), but vulvovaginal dryness/infection/discharge/pain are not prominent as labelled risks in the major semaglutide FAERS disproportionality paper retrieved here
You feel slightly queasy, particularly in the morning or after eating, but you can still function
a peptide approved for clinical use) and GLP-1 (purple), respectively
Why B-More Pearl Glow Jamies